Clinical Trials Logo

Ovarian Reserve clinical trials

View clinical trials related to Ovarian Reserve.

Filter by:

NCT ID: NCT03860805 Active, not recruiting - Laparoscopy Clinical Trials

SALpingectomy for STERilization (SALSTER)

SALSTER
Start date: April 3, 2019
Phase: N/A
Study type: Interventional

The SALSTER study is a register-based randomized clinical trial (R-RCT) that examines if laparoscopic salpingectomy instead of tubal ligation, as a contraceptive method, has no increased risk for complications and has no negative impact on ovarian function.

NCT ID: NCT03789123 Recruiting - Ovarian Reserve Clinical Trials

Effects of Dienogest and Dienogest Plus Estradiol Valerate in Ovarian Endometrioma

Start date: January 1, 2019
Phase: Phase 4
Study type: Interventional

Progesterone resistance in endometriosis is a known fact. The progestin derivatives used in endometriosis cause decidualization and atrophy of ectopic foci. Moreover, they inhibit neo-angiogenesis, provide suppress expansile/destructive growth facilitated by matrix metalloproteinases, and implantation of ectopic foci. The effect of drugs containing the estrogen-progesterone combination is mainly based on the inhibition of ovulation, decidualization and atrophy of ectopic foci. In estrogen-progesterone mechanism, it is known that estrogen has a progesterone receptor-enhancing effect, which may make progesterone more potent. Based on this, the investigators hypothesized that estrogen added to progesterone could lead to a further reduction in endometrioma size by various mechanisms which probably include the increased progesterone sensitivity in endometriosis. In addition, the investigators hypothesized that this therapy can alleviate the destructive effect of endometriomas on the ovarian reserve.

NCT ID: NCT03621683 Completed - Ovarian Reserve Clinical Trials

Antioxidants vs. Ovarian Bio-stimulation Therapy to Rescue the Ovarian Reserve

Start date: January 6, 2016
Phase: N/A
Study type: Interventional

Two group of patients were selected. Group 1 represents 46 patients that received ovarian-biostimulation monthly for three months. Group 2 represents 32 patients that received antioxidant therapy daily for 3 months. Results are noted and analysed. Both groups represent patients with procedures already ongoing, and with diagnosed poor or depleted ovarian reserve. The analysis has been made to compare the efficacy of both procedures.

NCT ID: NCT03620838 Recruiting - Endometrioma Clinical Trials

Endometrioma Per se Versus Treatment Related Reduction in Ovarian Reserve (ERROR-2 Trial)

ERROR2
Start date: March 1, 2019
Phase:
Study type: Observational

The present multi-center study aimed to evaluate whether endometrioma-associated decline in ovarian reserve is progressive in the absence of an intervention and is greater in magnitude than the natural decline over time. Also the affect of endometrioma treatment modalities like surgery or medical on the ovarian reserve over time.

NCT ID: NCT03492632 Completed - Psoriasis Clinical Trials

Ovarian Reserve in Patients With Psoriasis

Start date: October 25, 2017
Phase:
Study type: Observational

Psoriasis is a common autoimmune disease. It affects women of all ages including reproductive years. Autoimmune diseases including psoriasis are linked to premature ovarian reserve. This study aims to measure serum hormones including FSH,LH,E2,PRL and AMH (indicators of ovarian reserve) in women with and without psoriasis.

NCT ID: NCT03009370 Recruiting - Ovarian Reserve Clinical Trials

The Effect of the Ovarian Reserve on the Recurrent Pregnancy Loss

Start date: July 2016
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether ovarian reserve is related to recurrent pregnancy loss

NCT ID: NCT02995343 Recruiting - Ovarian Reserve Clinical Trials

Evaluation of the Ovarian Reserve in Patients Who Hypogastric Arteries and or Uterine Arteries Had Been Ligated

Start date: November 2016
Phase: N/A
Study type: Interventional

Patients who hypogastric arteries and/or uterine arteries had been ligated will be evaluated in terms of ovarian reserve markers such as anti-mullerian hormone levels, ovarian volumes, antral follicule count, follicule stimuli hormone and estrogen levels. Investigators will search their archives for finding suitable patients for study. Investigators will especially notice being at least 6 month time of interval between surgery and evaluation time. Ultrasound examination and taking blood sample will be performed on 2nd or 3th day of menstrual cycle. These results will be compared with normal postpartum women's results. It will be evaluated that there is or not any effect of the hypogastric arteries and/or uterine arteries on ovarian reserve

NCT ID: NCT02896023 Recruiting - Ovarian Reserve Clinical Trials

Predictors of Ovarian Reserve in Infertile Women

Start date: September 2016
Phase: Phase 4
Study type: Interventional

Patients will be subjected to: A. Clinical evaluation including history and examination B. Ultrasonographic evaluation of Ovarian Morphometry: - Patients will be evaluated in early follicular phase of the menstrual flow (cycle's days 1-3) by TVS scanning; using MINDRAY DP-1100 Plus Digital Machine, 7.5MHz, China, by only one examiner to avoid inter-observer variations. - Ovarian images will be procured in the sagittal and coronal planes and the frozen image reflecting the largest ovarian dimensions will be utilized for the measurement of ovarian length, width, and height (cm) as per standard clinical practice. Mean values of both ovaries will be used. Ovarian volume will be calculated from ellipsoid volume formula, {Ovarian volume = Ovarian Width (D1) × Ovarian Length (D2) ×Ovarian Height (D3) × 0 .523} - Antral follicle count will be determined for each patient C. Laboratory Evaluation: Blood samples will be collected in the early follicular phase. Samples will be immediately centrifuged and serum saved at -20 degrees for measurement of: - Anti Mullerian Hormone (AMH) - Follicle Stimulating Hormone (FSH) - Estradiol (E2) Using electro-chemiluminescence immunoassay (ELICA)

NCT ID: NCT02728245 Withdrawn - Endometriosis Clinical Trials

Trial Comparing Preoperative Dienogest Therapy Followed by Surgery vs. Upfront Surgery to Save Ovarian Reserve in Young Women With Ovarian Endometrioma

DOROSY
Start date: October 2017
Phase: Phase 2
Study type: Interventional

Randomized phase 2 trial comparing preoperative dienogest therapy followed by surgery vs. upfront surgery to save ovarian reserve in young women with ovarian endometrioma

NCT ID: NCT02685644 Not yet recruiting - Endometriosis Clinical Trials

Association Between Laparoscopic Removal of Endometriomas and Anti-mullerian Hormone Levels

Start date: April 2016
Phase: N/A
Study type: Observational

Laparoscopic excision of endometriotic cysts is the main stream surgical intervention for treatment of endometriosis. However there is evidence that intervention may effect ovarian reserve by destruction of healthy ovarian tissue during surgery. Available evidence on the topic are contradictory and employed research methodology are diverse. There is need for an adequately powered research with proper methodology to assess actual effects of surgery.